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Detection and accurate quantitation of viable Mycobacterium tuberculosis is fundamental to 
understanding mycobacterial pathogenicity, tuberculosis (TB) disease progression and outcomes; 
TB transmission; drug action, efficacy and drug resistance. Despite this importance, methods 
for determining numbers of viable bacilli are limited in accuracy and precision owing to inherent 
characteristics of mycobacterial cell biology—including the tendency to clump, and “differential” 
culturability—and technical challenges consequent on handling an infectious pathogen under biosafe 
conditions. We developed an absolute counting method for mycobacteria in liquid cultures using a 
bench‑top flow cytometer, and the low‑cost fluorescent dyes Calcein‑AM (CA) and SYBR‑gold (SG). 
During exponential growth CA + cell counts are highly correlated with CFU counts and can be used 
as a real‑time alternative to simplify the accurate standardisation of inocula for experiments. In 
contrast to CFU counting, this method can detect and enumerate cell aggregates in samples, which 
we show are a potential source of variance and bias when using established methods. We show that 
CFUs comprise a sub‑population of intact, metabolically active mycobacterial cells in liquid cultures, 
with CFU‑proportion varying by growth conditions. A pharmacodynamic application of the flow 
cytometry method, exploring kinetics of fluorescent probe defined subpopulations compared to 
CFU is demonstrated. Flow cytometry derived Mycobacterium bovis bacillus Calmette‑Guérin (BCG) 
time‑kill curves differ for rifampicin and kanamycin versus isoniazid and ethambutol, as do the 
relative dynamics of discrete morphologically‑distinct subpopulations of bacilli revealed by this high‑
throughput single‑cell technique.
For more than 100 years, counting Colony Forming Units (CFU) has been the gold-standard for quantifying 
viable Mycobacterium tuberculosis (Mtb) bacilli, both in vitro and ex vivo. However, despite being a methodologi-
cal foundation underpinning our scientific knowledge of Mtb, CFU counting has several technical and practical 
limitations, including cost and biosafety implications of maintaining multiple secondary cultures, time interval to 
results, loss of results from contamination, the inability to distinguish single cells from cell aggregates (clumps), 
and high intra- and inter-laboratory  variation1–3.
More fundamentally, under some conditions sub-populations of viable Mtb cells do not form colonies and 
are therefore unobserved by CFU  counting4–6. This is of particular relevance to tuberculosis (TB) diagnostics 
and research because of the prevailing theory that the existence of phenotypically heterogenous sub-populations 
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of bacilli—with differential metabolic or growth states—underlie profound aspects of TB disease biology, such 
as latency and the need for prolonged therapy to effect sterilising  cure7–10.
Improved methods for absolute counting of mycobacteria and phenotypic characterisation of subpopulations 
are therefore desirable. Flow cytometry (FCM) is a well-established technique for counting and characterising 
eukaryotic cells, and its potential to advance single-cell analyses in microbiology has been discussed in  depth11,12. 
Several groups have applied FCM to mycobacteria, including drug sensitivity  testing13–22, investigation of cell 
 biology23–28, early phase diagnostic test  development29,30, live/dead  discrimination31,32, and more advanced sin-
gle-cell  phenotyping23,33,34. Fluorescent dyes used by prior investigators include: probes of membrane integrity 
(the nucleic acid stains SYTOX-green33, SYTO-924,31,32, SYTO-BC24,32, SYTO-1616,28, SYBR-green  I30, propidium 
 iodide16,24,31,32,35, TO-PRO-3  iodide34, and auramine-O13,35,36); probes of metabolic activity (esterase substrate 
dyes fluorescein  diacetate14,17,20,21,37, and Calcein-violet33) and membrane potential (diethyloxacarbocyanine 
 iodide25,34 & rhodamine-12327). In general, absolute bacillary counts have not been derived from FCM; instead, 
batch measures of fluorescence (e.g. mean fluorescence signal)13–17,20,21,27,29,37, qualitative read-outs (e.g. scatter-
plots)18,26,34, or  percentages23,25,33 are reported. Growth conditions, processing (e.g. washes and fixation), and stain-
ing protocols vary widely. In the few cases in which the same stains have been used by different groups, results are 
often contradictory: for example, propidium iodide is reported to stain 0% of heat killed M. tuberculosis by one 
 study38, and 100% by  another31. No comparisons of FCM counts with CFU enumerations have been published.
The aims of the current study were:
(1) To develop and validate a method for absolute counting of mycobacteria in vitro using FCM.
(2) To explore the use of fluorescent dyes as probes of cell function to define subpopulations of bacilli in discrete 
physiological states.
(3) To compare dynamics of FCM-defined subpopulations and CFU in liquid cultures over time (growth 
curves), and over time in the presence of antimycobacterial compounds (time-kill curves).
We report a method developed on a low-cost flow cytometer (BD Accuri™ C6), using two commercially avail-
able fluorescent dyes (SYBR-Gold and Calcein-AM). The BD Accuri C6 flow cytometer has fixed alignment and 
pre-optimised detector settings, can record volume of sample processed without use of counting beads, and is 
small enough to fit on a benchtop or inside a bio-containment hood. SYBR-Gold (SG), a proprietary cyanine dye 
(excitation ~ 495 nm, emission ~ 573 nm) with > 1000-fold fluorescence enhancement when bound to nucleic acid, 
was designed for use in gel  electrophoresis39. SG has previously been shown to have substantially greater sensitiv-
ity than auramine-O for quantitative fluorescence microscopy of heat-fixed mycobacteria (99% versus 65–80%)40, 
but it has not been applied in FCM. Calcein-AM (CA) is a non-polar, lipophilic ester which becomes charged and 
fluorescent when hydrolysed by ‘house-keeping’ esterases ubiquitous in the cytoplasm of living  cells41. Hendon-
Dunn and colleagues previously showed that the fluorescence of mycobacteria stained with Calcein-violet-AM 
correlated with rate of growth in a chemostat and declined with antimicrobial killing of  bacilli33.
In the present study, we applied SG staining after heat killing bacilli to define a total intact cell count denomi-
nator; SG staining without heat killing to probe cell membrane integrity as a marker of death or damage; and 
CA staining without heat killing to probe metabolic activity as a marker of vitality.
Results
Setting fluorescence threshold values for FCM events improves validity of absolute bacilli 
counts. The BD Accuri C6 flow cytometer has a fixed dynamic range for voltage and gain, but allows thresh-
olds to be set on two signal values from light scatter and/or fluorescence channels. Signals below the set thresh-
old are not recorded as events. For absolute counting of cells, an optimal threshold is one that is not so high as to 
exclude true events (signals from cells), yet high enough that it excludes electronic noise and signal from debris 
(which can otherwise mask true events owing to the refractory period of photodetectors). Typically, thresholds 
are set on forward and/or side scatter of light (FSC and SSC), as this allows fluorescence-positive and -negative 
events to be recorded without biasing measurements from the fluorescence channels.
We investigated different threshold strategies as follows. Mid-log phase M. bovis BCG cultures were analysed 
after twofold dilution in 0.15% v/v Tween80 PBS solution. These were compared to an identical preparation of 
cell-free 7H9 broth as a negative control. Permutations of threshold settings were screened. In each case a gate 
was set around an apparent discrete population of events visible on a log(SSC) by log(FSC) plot, with the gate set 
manually to minimise the ratio between negative control and the paired BCG sample event counts. The optimal 
ratio (false positive event count in cell free broth divided by the paired BCG culture count) was defined as the 
false discovery rate; therefore, threshold parameters which maximised the absolute count in the BCG broth gate 
and minimised the false discovery rate were sought.
Optimal threshold values based on light scatter (FSC and SSC) were inconsistent across replicates and were 
never associated with false discovery rates less than 10%. By contrast, thresholding on SSC and fluorescence 
(FL1 533/30 nm) in heat-killed, SYBR-gold stained mid-log BCG consistently reduced the false discovery rate 
to < 0.5%, at the same time increasing absolute cell counts by more than one logarithm compared with threshold-
ing on light scatter alone on the same samples (Fig. 1). Further, this strategy reduced the coefficient of variation 
between technical replicates to < 5%, and gave near perfect linearity across serial dilutions of the same sample 
 (R2 > 0.99) (Fig. 1).
Clumping in mycobacterial broth cultures can be observed and quantified using FCM. In all 
mycobacterial broth cultures tested—M. bovis BCG, M. tuberculosis, and M. smegmatis, a second population of 
events with higher FSC and SSC became evident from early log-phase onwards, developing into the dominant 
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population in mid- or late log-phase (Fig. 2A). To investigate the nature of these distinct populations, events 
gated on the two light-scatter populations were sorted for downstream microscopy (Fig. 2B and C). This analysis 
revealed that the higher light-scatter population was composed of clumped cells, despite the fact that all cultures 
were grown in detergent (Tween80, 0.1–0.25% v/v) under continuous agitation (150–200 rpm), and notwith-
standing the use of sonication prior to flow cytometry.
Clumping is a major determinant of CFU count & can be controlled by needle emulsification, 
but not vortex, sonication or centrifugation. Having established the ability to quantify mycobacterial 
clumping in broth cultures using FCM, we next tested the comparative efficacies of standard microbiologi-
cal methods for clump dispersal. Vortex and sonication failed to disrupt the clumped population observed on 
FCM; by contrast, needle emulsification of the broth culture largely eliminated clumping (Fig. 3A). Disruption 
of clumps by needle emulsification increased the single-cell population seen on FCM, and therefore the CFU 
count, by more than 0.5 log (Fig. 3B). Needle emulsification was found to have the same effect on all mycobac-
teria tested, including M. tuberculosis (Fig.  3C). Larger clumps not disrupted even by needle-emulsification 
emerged in late-stage broth cultures (Fig. 4).
A standard method for preparation of single-cell suspensions of mycobacteria is centrifugation, based on the 
premise that cell clumps are selectively pelleted by gravity, with single cells remaining in  suspension42. However, 
using FCM we found that the ratio of clumps to single-cells was unaffected by centrifugation (Fig. 5).
Growth dynamics of FCM‑defined bacilli populations compared to CFU. A FCM protocol for 
absolute counting of bacilli—incorporating SYBR-gold or Calcein-AM staining, needle-emulsification to dis-
perse clumps, and thresholding on fluorescence (summarised in Fig. 6)—was used to explore dynamics of M. 
bovis BCG growth in broth culture. We defined three FCM populations using this protocol:
Figure 1.  Comparison of 3 thresholding strategies in heat killed and SYBR-gold stained mid-log phase BCG 
broth culture. (A) Example FCM plots for three thresholding strategies (rows 1–3) applied to M. bovis BCG 
broth culture (column 1) and cell-free broth (cell-free negative control, column 2). Counts are extracted for 
the gated population (events within dashed red line), which is placed to maximise the count in BCG broth 
and minimise the count in the cell-free control. Recorded events in the low light scatter value thresholding 
(first row) are dominated by debris/noise, seen as a dense population with low SSC and FSC values in lower 
left quadrant; this is equally apparent in the cell-free control. Higher light scatter thresholding (second row) 
excludes these events, but still records a substantial portion of higher SSC/FSC noise (seen in cell-free control), 
and the threshold level appears to bisect the ‘real’ cell population; i.e., losing cells from analysis. By contrast, the 
thresholding based on fluorescence (third row) is qualitatively better, with very few false positive events in the 
cell-free control, and detection of a discrete cell population in BCG broth which is not artificially bisected. (B) 
Greater internal consistency in the FL1/SSC thresholding strategy, with less error across serial dilutions of a M. 
bovis BCG culture. Quantitative evidence of improved absolute count validity includes a lower false discovery 
rate (FDR, defined as false positive cell count in cell-free control divided by paired cell count from broth); lower 
coefficient of variation (CV, calculated by standard deviation/mean from 5 technical replicates, averaged for 3 
biological replicates); and higher  R2 from linear fit across serial dilution series (one biological replicate as shown 
in figure; p < 0.001 for F test comparing FL1/SCC to either FSC/SSC strategy; 95% confidence intervals for linear 
fit shown with grey shaded areas).
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1. Calcein-AM-positive (CA +) live sample stained with Calcein-AM, to give an esterase positive, or ‘metaboli-
cally active’, cell count.
2. SYBR-gold-positive (SG +) live sample stained with SYBR-gold, to count cells which have membranes perme-
able to SYBR-gold, implying membrane damage.
3. Heat-killed ‘total cell count’ (HK) sample incubated in water-bath at 60 °C for 12 min to permeabilise cell-
membranes, followed by SYBR-gold staining. This is proposed to give a total count of intact cells containing 
nucleic acid, and therefore provides a denominator for calculating the proportion of cells which are CA + , 
or SG + , or colony-forming. The selected heat-kill time and temperature were selected as the minimum to 
reliably maximise the HK count.
Figure 2.  Identifying mycobacterial clumping with FCM. (A) 2D-density plots of FSC v SSC on log scale for a 
culture of M. bovis BCG grown with 0.15% v/v Tween80 at 180 rpm. Plots are from samples taken at 48, 96, 144, 
and 240 h after bacilli were sub-cultured from a log-phase starter culture into pre-warmed broth (early, early-
mid, late-mid and late log-phase, respectively). Samples were diluted tenfold or 100-fold (later samples) in 0.25% 
v/v Tween80 PBS and sonicated for 60 s prior to flow cytometry. The tail of higher SSC and FSC events at 48-h 
is seen to develop into a discrete second subpopulation by 96-h, which continues to expand into a higher SSC 
and FSC region and become the predominant subpopulation by the end of log-phase. All plots are constructed 
from 5000 events. (B) M. tuberculosis and M. smegmatis processed as above (both mid-late log phase) also 
develop dual populations separating on FSC and SSC, replicating the M. bovis BCG findings. (C) M. smegmatis 
sample was run on a BioRad S3 cell sorter with P1 and P2 sorted for downstream fluorescence microscopy 
(representative images shown). M. smegmatis was used for cell sorting owing to concerns about aerosolising 
M. tuberculosis or M. bovis BCG. P1 comprised majority single cells or doublets, while P2 comprised majority 
clumps (manually quantified from fluorescence microscopy images).
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Figure 3.  Needle-emulsification, but not vortex or sonication, disrupt clumps and increases cell counts. Mid-log phase 
culture of M. smegmatis (A, B) and M. tuberculosis H37Rv (C) grown in 0.15% v/v Tween80 7H9 with 150 rpm agitation and 
diluted tenfold in 0.15% v/v Tween80 PBS and stained with Calcein-AM prior to FCM on a BD Accuri C6. Data acquisition 
with thresholds SSC > 1000 and FL1 > 2000. Samples were processed by 60 s vortex, or by 60 s vortex followed by 5 min 
sonication in water bath, or by both these methods followed by needle emulsification (12 passes through a double Luer lock-
ended, 25 Gauge, 4-inch, micro-emulsifying needle with a reinforcing bar (Cadence Inc.). (A) Two populations are seen which 
are differentiated by light-scatter: single cells (P1) and clumps (P2). Qualitatively, vortex and sonication processing did not 
disrupt P2 population (clumps), but needle emulsification (far right plot) shifted events from predominantly P2 (clumps) to 
predominantly P1 (single cells). (B) Counts of CFUs or FCM events with three-replicates from 3 independent cultures (purple, 
green, yellow dots). Emulsification resulted in a greater number of CFU and decreased the P2 count while increasing the P1 
count substantially. The apparent total cell counts were increased by emulsification by an order of magnitude: both CFU count 
and total flow cytometry CA positive count increased by half to one unit on log scale. This can be interpreted as resulting from 
clumps (P2 population) being disaggregated into single cells (P1). The p-values were determined from repeated-measures 
ANOVA by cell-disruption method. (C) Needle emulsification procedure has same effect on clumping in M. tuberculosis 
H37Rv (processed without vortex and sonication steps).
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CFU counts after needle emulsification were determined in parallel (Fig. 6).
In all culture growth phases (lag, log, stationary), the HK cell count was greater than CA + , SG + , or CFU 
counts (Fig. 7A), and was accepted as a total cell count. During log-phase, most cells were CA + and colony 
forming, with SG + cells constituting a minority sub-population (Fig. 7B–D). When entering stationary phase, 
CA + and CFU counts started to fall, with a simultaneous rise in SG + cells, which subsequently became the 
dominant subpopulation (Fig. 7B–D).
Figure 4.  Clumps which are resistant to disruption by emulsification eventually emerge in late log-phase 
cultures. (A) M. bovis BCG culture in 0.15% v/v Tween80 7H9 with 150 rpm agitation and diluted tenfold 
in 0.15% v/v Tween80 PBS before bacilli were heat-killed and stained with SYBR-gold. Samples were needle-
emulsified (12 passes through a double Luer lock-ended, 25 Gauge, 4-inch, micro-emulsifying needle) prior 
to FCM on BD Accuri C6; data acquisition with thresholds SSC > 1000 and FL1 > 1000. Timepoints are days 
post inoculation into pre-warmed broth from log phase starter culture. A long tail of clumps, extending into 
the upper-right quadrant of higher SSC and FSC, emerges from around day 9, at  OD600 ~ 0.3. Clumps were 
defined as events with SSC and FSC values greater than 10-log and 11-log (events in upper right quadrant of 
plots). Density distributions shown are derived from 5000 recorded events in each plot; initial starter cultures 
are a mixture of single cells and clumps (still visible on day 2 plot); early exponential growth is predominantly 
in the single cell population; later (after day 8) growth is predominantly of clumps. (B) Clumps and single cells 
quantified by flow cytometry (four independent replicates of data represented by A; replicates are shown with 
different colours). Emulsification appears able to disrupt clumps until late log phase (~ day 8), when both the 
ratio of clumps to single cells and size (approximated by mean FSC) of clumps rise rapidly. Line of best fit with 
95% confidence interval band is a LOESS regression line ignoring dependence by replicate.
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Correlation between CFU and CA + counts was growth-phase dependent (Fig. 7E) with close co-variance in 
early-to-mid-log phase progressively diminishing in late-log (when CFU > CA +) and stationary phase (when 
CA +  > CFU). Total population growth rate—defined using the instantaneous rate-of-change of the log HK total 
cell count (the slope of the tangent to the curve at a given timepoint, i.e. the first-derivative)—correlated with the 
proportion of bacilli which were CA + , but not the proportion of bacilli forming colonies (Fig. 7F).
In vitro pharmacodynamics of M. bovis BCG by CFU and FCM counting. Having established 
growth dynamics in the absence of antimicrobials, the FCM count method was applied to pharmacodynamic 
(PD) time-kill analysis of M. bovis BCG. Starter cultures (100 ml in 500 ml tissue culture flasks containing 0.15% 
v/v Tween 80 7H9 medium) were grown to a density of ~ 2 ×  105 CA + cells per ml, then split into 20 ml samples 
Figure 5.  Ratio of clumped to single-cell M. smegmatis is not altered by low-g centrifugation. Three mid-log 
phase M. smegmatis cultures grown in 0.05% Tween80 7H9 with continuous agitation at 150 rpm (3 biological 
replicates shown in blue, green and red), processed three ways. Control sample:  10–1 dilution in 0.1% Tween80 
PBS, no physical disruption. Centrifuge sample: 10 ml + 5 ml 0.1% Tween80 PBS; spun in 15 ml centrifuge 
tubes at 120 × g for 8 min with no brake. Emulsified sample:  10–1 dilution in 0.1% Tween80 PBS, 12 × needle 
emulsified. Supernatant used for counts, as per ref 42 main manuscript. All samples heat-killed and stained with 
SYBR-gold prior to flow cytometry on BD Accuri-C6, with thresholding on SSC and FL1. Data are for three 
technical replicates of each culture. (A) Qualitatively, the FSC by SSC flow plots were similar for centrifuge 
method and control, compared to the needle-emulsified sample where the cell-clump population (P2) was not 
evident. (B) The ratio of clumps to single cells (p2:p1) was the same in the control and centrifuge preparations, 
but was much lower (and with less variation across replicates) with emulsification. Apparent cell counts were 
lower with centrifugation (owing to loss of cells in pellet) and higher with emulsification (owing to disruption of 
clumps). Three independent culture replicates (read, blue, and green; each processed 3 times in each condition 
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in 50 ml conical flasks. Antimicrobials (rifampicin, isoniazid, kanamycin, ethambutol) were added at a range of 
final concentrations in multiples of their minimum inhibitory concentration (MIC99), and bacilli quantified at 
0, 24, 48, 72 and 120 h using FCM and CFU counting. The experiment was repeated on three separate occasions 
to ensure independent biological replicates.
Raw FCM data plots for heat-killed, Calcein-AM, and SYBR-gold stained preparations from one of three 
independent replicates are shown for selected conditions in Fig. 8A–C. Time-kill curves based on absolute counts, 
and proportions (CA + /HK, SG + /HK, CFU/HK counts), are shown in Figs. 9A and 9B, respectively.
Compared to antimicrobial-free controls, total cell count (HK count) growth was generally impeded by 
the presence of antimicrobials, although exponential growth still occurred with ethambutol and kanamycin at 
0.5xMIC concentration of both antimicrobials. Critically, even at high concentrations of all antimicrobials tested, 
HK count did not show dramatic reduction over 120 h of exposure.
By contrast, CA + and CFU counts fell substantially over that time period. Notably, CFU counts declined 
earlier than CA + counts for all antimicrobial tested for all inhibitory concentrations. Rifampicin or kanamycin 
exposure resulted in an earlier decline in CA + counts than was observed for isoniazid or ethambutol, which at 
high concentrations showed an initial increase in proportion of cells CA + at 24 h, before a sustained fall to day 5.
Because a fraction of cells were SG + under any condition, the major driver of absolute SG + count was the 
total cell count, this can be seen in the antimicrobial-free controls where the highest SG + counts were seen at 
late stages of growth. The proportion SG + was, however, antimicrobial dependent: SG + cells were a majority by 
day 5 in all supra-MIC concentration conditions, but the rise in the SG + proportion occurred earlier and was 
larger for isoniazid and ethambutol than for rifampicin or kanamycin.
To summarise differing effects by antimicrobial and subpopulation, sigmoidal  Emax models were fitted to the 
time-kill data (Fig. 10). Based on CFU time-kill curves, rifampicin, kanamycin, and isoniazid all have similar 
 Emax values, while ethambutol is substantially lower. CA + time-kill  Emax was higher for rifampicin and kanamy-
cin; and lower for ethambutol and isoniazid. The pattern was reversed for the effect on SG + proportion. Finally, 
while the effects of antimicrobials on total cell count (HK count) were modest, they did differ by antimicrobial, 
with  Emax highest for rifampicin and lowest for ethambutol.
Subpopulations of cells by SYBR‑gold staining characteristics. In addition to count data, qualita-
tive differences in fluorescence were seen in live bacilli stained with SYBR-gold, with two subpopulations of 
SG + cells separated by FL1 intensity (most distinct after 72 h of isoniazid or ethambutol exposure, Fig. 8C). We 
hypothesised that two populations of bacilli with different SG staining properties were revealed by the mem-
brane permeabilising effects of these antimicrobials. To investigate this possibility, we developed a protocol for 
permeabilising M. bovis BCG membranes without bacillary destruction (detailed in methods), and character-
ised these subpopulations under different antimicrobial conditions by quantifying them and through direct 
microscopy after cell-sorting.
Dual SG + subpopulations were discriminated by distribution peaks (Fig. 11A) and were seen under all condi-
tions, including growth without antimicrobial exposure (Fig. 11B) with one population (labelled P2) returning 
a mean fluorescence two-fold higher than the other (labelled P1) (Fig. 11A and C). Fluorescent microscopy of 
cell-sorted samples showed that, compared to P1, P2 bacilli were longer (mean 4.0 μm versus 2.5 μm), with double 
the number of fluorescent foci (mean 6.1 versus 3.2) (Fig. 11D). The ratio of P2 to P1 cells in antimicrobial-free 
cultures was median 1.75, and non-significantly higher when bacilli were exposed to rifampicin or kanamycin 
(median 1.83 and 1.86, respectively), but significantly higher after exposure to ethambutol or isoniazid (median 
2.11 and 2.00, respectively; p < 0.001 for both by rank-sum test). The P2:P1 ratio when bacilli were incubated 
with both rifampicin and isoniazid matched rifampicin mono-exposure rather than isoniazid mono-exposure 
(Fig. 11E).
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Discussion
Detection and accurate quantitation of Mycobacterium tuberculosis is fundamental to understanding TB biology. 
Growing evidence suggests that culture-based methods detect only a sub-population of  bacilli4,5, yet these meth-
ods remain standard in mycobacterial sciences. By contrast, in response to the analogous problem of differential 
culturability of microbiota in environmental substrates, FCM has been adopted as an essential method in envi-
ronmental microbiology  research60,61, and  industry62,63. We developed a novel FCM-based method for absolute 
Figure 7.  Bacillary population dynamics during standard growth in culture. Four independent M. bovis BCG 
cultures (replicates i to iv), grown in 50 ml 0.15% v/v Tween80 7H9, 500 ml tissueculture flasks at 150 rpm 
agitation, were serially quantified by CFU and FCM counts (method outlined in Fig. 6) between 2 and 15 days 
after inoculation into pre-warmed broth from a log phase starter culture. (A) Using the heat-killed SYBR-gold 
stained (HK) cell count as total cell denominator, the proportion of bacilli which were Calcein-AM positive 
(CA +), colony-forming (CFU), and permeable to SYBR-gold without heat-killing (SG +) are shown over time 
post inoculation (B–D); each replicate is plotted using a different colour; LOESS line-of-best-fit and 95% CI 
shown for the observations aggregated across replicates. Linear correlation between log CA + and log CFU 
counts was strong (E), but with a dependency on phase of growth (time in days from inoculation shown by 
colour; non-constant variance (NCV) test for heteroscedasticity, p = 0.03, dashed lines are +/− 1 SD of residual 
variation). Rate of population growth is defined as instantaneous rate of change in total cell count (slope of 
the tangent to the curve at a given timepoint; i.e., first derivative of the growth curve). Rate of total population 
growth was regressed on proportion of bacilli able to form colonies, or on proportion CA + (F), at any given 
timepoint, with each replicate (i to iv, again shown by colour) allowed to differ by intercept but not slope.
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Figure 8.  Raw FMC plots of HK, CA + , and SG + events for selected antimicrobial conditions and timepoints. 
Raw FMC data from one of three independent replicates. SYBR-gold stained heat-killed (HK) samples (A, left), 
Calcein-AM stained live samples (B, middle), and SYBR-gold stained live samples (C, right), by antimicrobial 
condition (rows) and time-point (hours) post introduction of antimicrobials (columns). Antimicrobial indicated 
by letter prefix (E, ethambutol; H, isoniazid; K, kanamycin; R, rifampicin) and concentration in multiples of 
 MIC99 by suffix letter (e.g., R4 = rifampicin at 4 × MIC). FCM events in each plot are coloured by K-means 
clustering on all light-scatter and fluorescence dimensions—an unsupervised classification (machine learning) 
algorithm used to define subpopulations without subjective manual placement of gates.
Figure 9.  Time-kill curves generated through FCM defined cell populations and CFU counts. Data from 
three replicates. Counts (left panel) and proportions (right panel) by cell population [CA +  = Calcein-AM-
stained in live samples; CFU = colony forming units; SG +  = SYBR-gold-stained in live samples; HK = SYBR-
gold-stained in heat-killed samples] over time by antimicrobial condition. Antimicrobial indicated by letter in 
rows (E, ethambutol; H, isoniazid; K, kanamycin; R, rifampicin; CTRL, antimicrobial-free [“Nil Abx”] broth) 
and concentration in multiples of MIC in columns. Non-parametric Loess regression line and shaded 95% 
confidence intervals shown. Proportions are derived using HK count as a total cell count denominator (i.e. 
CA + /HK, SG + /HK, CFU/HK).
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Figure 10.  Emax models applied to time-kill data from FCM defined cell population and CFU counts. The 
time-kill data in Fig. 9 were modelled using a linear mixed-effects model to extract an estimate of mono-
exponential elimination rate for each antimicrobial condition as a summary pharmacodynamic (PD) measure 
for each FCM defined cell population and CFU counts. Antimicrobial effects extracted from these models were 
related to drug concentration for each antimicrobial using a standard sigmoid  Emax PK/PD model, shown here 
for each antimicrobial (columns) and each cell population (rows). *A sigmoidal  Emax model could not be fit for 
rifampicin %SG + growth rate data due to non-convergence; the fit shown is from a model excluding the outlier 
data point at concentration 0.005 mg/ml (− 5.3 on log scale). When this data point (indicated in grey) was 
excluded, the model converged.
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counting of mycobacteria in liquid cultures. While several groups have reported characterising mycobacteria 
using FCM, our method is the first to give absolute counts, and can be used to quantify total cell denominator, 
the presence of cell-clumps, and sub-populations with metabolic activity (using the esterase substrate, Calcein-
AM) or membrane permeability (using the nucleic acid stain, SYBR-gold). Our results highlight some critical 
shortcomings of current ‘gold-standard’ methods for mycobacteria quantification. We also illustrate how the 
FCM absolute count method can be used for high-throughput, rapid investigations of phenotypic heterogeneity 
in mycobacteria and demonstrate the capacity to extract pharmacodynamic data using this approach.
Using our FCM method we found that we could reliably identify a subpopulation of the batch culture com-
prising clumped cells. Further investigations revealed that mycobacterial cultures remain prone to cell clumping 
in spite of commonly used measures to reduce their formation and to disrupt these before experimentation. We 
found that sample processing has a major impact on clump-dispersal, such that needle emulsification could 
Figure 11.  Distinct pharmacodynamics of SYBR-gold-positive sub-populations. (A) FCM plot for ethambutol-
treated (4 × MIC, 48 h), SYBR-gold stained live bacilli. Two discrete sub-populations are visible, separated by 
approximately two-fold difference in fluorescence. These sub-populations were visible in most ethambutol- 
or isoniazid-treated cultures, but not readily visible in rifampicin or kanamycin FCM plots (Fig. 8). (B) 
After membrane permeabilization at room temperature, these distinct sub-populations are visible under all 
conditions including the antimicrobial-free control. (C) Clustering algorithm (Gaussian mixture model) used 
to label bacilli as P1 (lower SG fluorescence) or P2 (higher SG fluorescence). (D) P1 and P2 bacilli sorted for 
downstream microscopy show different morphologies. A random selection of bacilli images from sorted P1 and 
P2 sub-populations were measured along their longitudinal axis using ImageJ to assess length and fluorescence 
profile (two examples shown). P2 bacilli were longer than P1 bacilli (mean 4.0 µm versus 2.5 µm) and contained 
approximately double the number of fluorescent ’peaks’ (mean 6.1 versus 3.2; peaks defined by local maxima in a 
LOESS smoothing function applied to the fluorescence profile plots). (E) The ratio of P2:P1 bacillary counts was 
dependent on antimicrobial: isoniazid and ethambutol exposure caused a relative rise in P2 bacilli compared 
to control, but the same effect was not seen for rifampicin or kanamycin. For the rifampicin plus isoniazid 
(Rif + Inh) combination treatment, the P2:P1 ratio matched the ratio obtained for rifampicin monotherapy, 
rather than isoniazid. All p-values were determined from a linear regression of P2:P1 ratio on antimicrobial 
category, with the antimicrobial-free control as reference category. (F) Non-parametric Loess regression fitting 
P2:P1 ratio to log2 concentration (black line with shaded 95% confidence interval) for each antimicrobial 
condition suggests the pharmacodynamic effect may be non-linearly dependent on concentration.
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increase CFU count approximately two-fold even in early log-phase growth. This implies the potential for sig-
nificant noise and bias in CFU determination, especially for late-log and stationary phase cultures, given that 
the method depends on serial dilution of dispersed cultures. Our data suggest published  protocols42 for produc-
ing single cell suspensions using centrifugation have no effect on the ratio of clumps to single cells. Using the 
needle-emulsification and FCM counting methods described would be expected to reduce experimental error in 
mycobacterial research where bacilli counts are needed to standardise starting conditions, or where the number 
of bacilli is the dependent variable of interest. Further, under antimicrobial-free early-mid log-phase growth 
conditions, CA + bacillary counts correlate well with CFU counts and can be obtained within 90 min using 
low-cost reagents indicating that the FCM counting method is a practicable alternative to current culture-based 
methods of estimating cell numbers.
Our FCM method is distinct from previously described mycobacterial FCM protocols primarily because 
a fluorescence threshold is used to determine when FCM events are recorded. This means that fluorescence-
negative events (e.g. a Calcein negative cell) cannot be directly observed but permits accurate absolute counts to 
be reported for the first time in mycobacterial flow cytometry. Because an absolute cell count denominator can 
be established with SYBR-gold staining of heat-killed bacilli, the proportion of bacilli with a given characteristic 
can be ascertained. Importantly, a total cell denominator also allows the proportion of bacilli forming colonies 
to be measured, which was about 60% in mid-exponential phase of growth in liquid culture.
Our pharmacodynamic results build on previous mycobacterial flow cytometry work reported by Hendon-
Dunn et al.33 We replicate their finding that pharmacodynamic flow cytometry profiles based on fluorescent 
probes of cytoplasmic esterase metabolism and cell wall integrity are different for drugs with different mecha-
nisms of action. We found that the cell wall acting drugs isoniazid and ethambutol were associated with a rela-
tively rapid rise in SG + cells, while the cytoplasmic targeting rifampicin and kanamycin showed relatively early 
decline in CA + bacilli. However, Hendon-Dunn et al. observed only a moderate, concentration-independent 
effect of rifampicin on Calcein-violet positive bacilli over the first 4 days of exposure. By contrast we found that 
rifampicin had an early, concentration-dependent effect on CA + cells, and this effect was substantially greater 
than for isoniazid. Hendon-Dunn et al. measured relative proportions of Calcein positive and negative cells in 
cytometry plots, while our method produces absolute cell counts. If antimicrobials have differential effects on 
the total cell count (which we observed), relative proportions could be unreliable readouts of drug effect (owing 
to a ‘denominator fallacy’). In addition, the manual gating strategy used by Hendon-Dunn et al. does not appear 
to capture the shift in mean Calcein fluorescence seen under early rifampicin action, whereas the unsupervised 
classification approach implemented in this method does.
Again, based on absolute counts, we were able to directly and quantitatively compare CFU and FCM sub-
population pharmacodynamics. Under all antimicrobial conditions tested, elimination of colony forming bacilli 
occurred substantially earlier than the decline in CA + bacilli or the rise in SG + bacilli. This means that, at some 
time points a majority of bacilli are structurally intact with evidence of metabolic activity but do not form 
colonies. Further, we show that pharmacodynamic effect estimates based on FCM-defined subpopulations give 
different read-outs from those based on CFU counts: the rifampicin effect on CFU elimination is similar to 
isoniazid, but rifampicin elimination of CA + bacilli is markedly greater; rifampicin also has a larger effect on 
total cell count than the other antimicrobials tested. Rather than simply being a rapid surrogate for CFU counts, 
the FCM method therefore provides information on antimycobacterial drug pharmacodynamics not captured 
by CFU counting, but it is unknown if this information is clinically meaningful. Terminally injured bacilli may 
simply retain metabolic activity with residual enzyme activity in a non-viable cell. Alternatively, as non-growing 
metabolically active (NGMA) cells can be capable of  resuscitation55, this may represent an adaptive response to 
antimicrobial stress by reducing the physiological consequences of target  inhibition56. FCM probes of metabolic 
and structural integrity would then be more meaningful measures of viability. The latter would be a simple 
explanation for the lack of correlation between culture-based surrogate endpoints (early bactericidal activity 
measured using CFU counting, 2-month culture conversion, modelling serial CFU counts or time-to-positivity 
in liquid culture) and probability of achieving sterilising cure in clinical tuberculosis  pharmacodynamics43 and 
warrants testing in clinical samples.
If NGMA bacilli are an adaptive response to antimicrobial exposure then the ability to characterise them 
using high-throughput methods is critical. By staining live but membrane-permeabilized bacilli with SYBR-
gold, we observed two distinct bacilli sub-populations, separated by a two-fold difference in mean fluorescence. 
We found this phenotype-variation was specifically induced by exposure to isoniazid or ethambutol, but the 
isoniazid effect was inhibited by the presence of rifampicin. Importantly, the induction of this phenotype could 
be seen at antimicrobial-condition-timepoints where > 99.9% of CFU were already eliminated (e.g. after 72 h of 
isoniazid exposure at 4 × MIC concentration). After cell-sorting, bacilli from the two-fold brighter subpopula-
tion were found to be longer with double the number of fluorescence foci. Given that SYBR-gold fluoresces 
when bound to nucleic acid, this implies a bacillary phenotype with double the nucleic acid content, and this 
phenotypic heterogeneity may therefore represent different numbers of chromosome copies. In a non-human 
primate model of tuberculosis, “chromosomal equivalents” remain abundant in granulomas that have been 
sterilised (rendered CFU-negative) by isoniazid  therapy64. Peaks separated by a twofold difference in fluores-
cent intensity after staining with ethidium bromide or PicoGreen have been used extensively to define multiple 
chromosome numbers in E. coli44–46. Further, several groups have associated polyploidy in E. coli with elongated 
“filamentous” persister cells capable of accelerated antibiotic resistance  evolution46–48. In the Wayne model of 
non-replicating persistence during hypoxia-induced stress, mycobacteria are found to be  diploid49. In an in vitro 
foamy-macrophage model, intracellular Mycobacterium avium has been shown to enter a reversible dormancy 
state where the bacilli elongate but do not divide (implying they would not form colonies)57; it is suspected that 
these elongated, metabolically-active but non-replicating mycobacteria may be  polyploid50. We speculate that 
polyploid, metabolically-active but non-colony forming bacilli which are preferentially induced by isoniazid but 
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not rifampicin may be of significant clinical interest. If they represent a drug-tolerant phenotype unobserved 
by CFU counting, this could explain the fact that, while isoniazid has the most potent early bactericidal activity 
(EBA, measured by CFU counting), only rifampicin-containing regimens can reliably effect sterilising cure after 
6-months (“short-course”) therapy. That drug resistant mutants emerge from phenotypically drug tolerant cells 
has recently been described for clinical isolates of Staphylococcus aureus58, a similar mechanism might exist for 
mycobacteria. The spontaneous drug resistance mutation rates for M. tuberculosis in vitro range from  10–7 to  10–9 
and it is somewhat unclear if estimated total mycobacteria numbers in vivo allow for development of multidrug 
resistance through the simple product of these  probabilities59— particularly if drug resistance emerges de novo 
after EBA has eliminated most bacilli observable by culture. A population of bacilli, unobserved by CFU counting 
but capable of elongation and polyploidy, implies ongoing chromosome replication after antimicrobial exposure 
and a pool of drug-tolerant cells from which drug resistance could emerge.
We used batch cultures in this work which may have limitations. Unexplained variation in FCM sub-pop-
ulation proportions and growth rates between biological replicates, even under antimicrobial-free conditions 
were seen (e.g. Figure 7B and F). Steady-state cultures—such as the chemostat method used by Hendon-Dunn 
in their flow-cytometry study—are known to improve reproducibility compared to batch cultures in microbial 
proteomics and transcriptomics  analyses51,52, and are likely to be a major advantage in pharmacodynamic studies. 
Indeed, cell populations in batch cultures can show complex, non-linear growth patterns in cell size and DNA 
 content44 (which are major read-outs from the current implementation of our FCM absolute count method). 
However these limitations of batch cultures, match those of currently implemented culture methods in research 
laboratories and are expected to add noise rather than bias to our results.
Overall, our results add to the evidence of limitations in established methods for enumeration of bacilli and 
support the utility of FCM as a high-throughput, single-cell, culture-independent quantitative tool for the study 
of mycobacteria in preclinical drug development and ultimately in clinical samples.
Methods
Cytometry. Flow cytometry was performed on a BD Accuri C6 with manufacturer standard fluorescence 
detector set-up (FL1, 533/30 nm; FL2, 585/40 nm; FL3, > 670 nm; FL4, 675/25 nm) and data acquisition with 
BD Accuri C6 software including recording processed sample volume. Quality assurance was performed using 
fluorescent beads as per manufacturer protocol. Manual and extended cleaning cycles were performed at the 
beginning and end of each flow cytometry session with verification of low event rate in filtered PBS before each 
run. Cell-sorting experiments were performed on a Bio Rad S3 cell sorter or FACS Vantage with voltage and gain 
set to recreate BD Accuri C6 plots. All microscopy was performed on a Zeiss Axio Observer 7.
Sample processing. Needle emusfication was performed with 12 passes through a double luer-lock ended, 
25 Gauge, 4-inch, micro-emulsifying needle (CAD7974 Sigma Aldrich). Sonication of cultures prior to FCM 
to assess effect on clump dispersal was performed by submerging 1 ml centrifuge tubes attached to a flotation 
device in a benchtop ultrasonication water-bath three times for 30 s duration (Ultrawave U300HD 30 KHZ; 
Ultrawave, Cardiff, UK). Heat-kill of mycobacterial samples for “HK counts” was by immersion of aliquots in a 
waterbath at 60 °C for 12 min. Removal of antimicrobials prior to CFU plating was by pelleting a 1000μL sample 
(diluted twofold from 500 μL with PBS) at 18000 g for 12 min, removing 900μL of supernatant, resuspending 
100μL residual volume in 900μL of 0.22um filtered 0.15% v/v Tween 80 sterile PBS by pipetting, repeated twice 
(for 10 × 10 = 100-fold dilution). This will have diluted antimicrobial in solution (unbound) 200-fold prior to 
plating.
Culture conditions. Liquid media was prepared from Middlebrook 7H9 media (211,887 BD Diagnostics) 
and 0.22um filtered deionized water according to manufacturer instructions. This was supplemented with 10% 
v/v Middlebrook OADC (212,240 BD Diagnostics), 0.2% v/v glycerol and 0.15% v/v Tween 80. All broth was 
autoclaved prior to supplementation, and 0.22um filtered prior to use. Liquid cultures were at 37 °C in the dark 
with 150–200 rpm agitation in 50 ml sterile polyethylene conical flasks in an incubator with an orbital shaking 
system (model LM-570; MRC Laboratory Instruments Group, London, UK).
Middlebrook 7H10 (262,710 BD Diagnostics) agar was prepared with 0.22um filtered deionized water accord-
ing to manufacturer instructions, with v/v 0.5% glycerol added before autoclave sterilisation. When cooled to 
45 °C, v/v 10% ADC supplement was added and tri-segmented plates poured to depth 5 mm. For CFU counting, 
tenfold serial dilutions of samples were prepared in 96-well plates using 0.22um filtered 0.15% v/v Tween 80 
sterile PBS. Each segment of a plate was inoculated with 50uL of serial dilutions and spread using disposable, 
sterile loop spreaders. CFU counts were performed with threefold technical replicates and counts averaged. 
Colony counts between 1 and 100 per segment were accepted and, after adjustment for dilution, averages across 
dilutions were made where available. Counts were performed on 3 occasions (14, 21, and 28 days) to allow 
colonies to be counted before overgrowth.
Reagents. Primary stock dilutions of antibiotic powders were made in 100% DMSO and frozen at − 20 °C 
protected from light. Fresh working dilutions were prepared in PBS prior to each experiment, 0.22 nm filtered, 
and stored wrapped in tin foil at 2–5 °C refrigeration. Final concentrations of antimicrobials used in M. bovis 
BCG time-kill experiments are reported in multiples of the MIC as indicated. The MIC were: rifampicin, 0.01 μg/
ml; isoniazid 0.125 μg/ml; kanamycin 1.0 μg/ml; ethambutol 1.0 μg/ml.
Calcein-AM 50 μg vials (ThermoFisher, C3100MP) were reconstituted in 50μL of DMSO on the day of each 
experiment, further diluted to 200μL with PBS for “working stock”. For cell staining, 5μL of working stock was 
added per 100μL of sample, with pipette mixing, then incubated in the dark at room temperature for 45–60 min 
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before resuspension of bacilli with pipetting. SYBR-gold propriety stock (ThermoFisher, S-11494) was diluted 
1000-fold in PBS, aliquoted and frozen at − 20 °C until use. After thawing aliquot, a further tenfold dilution (to 
 10–4) in PBS was performed, and 5μL of this working stock added per 100μL of sample to be stained, with pipette 
mixing, followed by incubation in dark at room temperature for 45–60 min before resuspension of bacilli with 
pipetting.
Permeabilization of live cells. For the investigation of SG stained subpopulations, published methods for 
permeabilizing mycobacterial cell walls were reviewed; those with highest reported success and best description 
of  validation53,54 were taken forward for testing and adaptation. Permutations of paraformaldehyde / ammonium 
chloride fixation, ethanol, hydrochloric acid, detergents, and lysozyme were tested at different concentrations, 
incubation times, and temperatures also assessed iteratively. This led to a final method for reliable permeabi-
lization of BCG bacilli without substantial cell loss, such that over 80% of bacilli could be SYBR-gold stained 
(compared to the heat-killed total cell count denominator gold standard). In the final method, a 500μL sample 
was diluted to 1 ml with PBS v/v 0.15%Tween 80, without wash step or fixation. After needle emulsification, 
lysozyme was added to final conc 0.1 mg/ml, and the sample incubated for 45 min at 37 °C. 500 µl triton-X-100 
was then added to final concentration v/v 0.2%. This was pelleted (16000 g, 5 min) and re-suspended in 500 µl 
PBS-tween; 40 µl working stock SYBR-gold added and incubated at room temperature for 2–4 h.
Data analysis. Raw flow-cytometry data was extracted from.fcs files exported from BD Accuri C6 software 
using flowCore (v 2.0.1) Bioconductor  package65 and all analysis performed in Rstudio v1.1.463. Rather than 
using manually placed gates to classify events, unsupervised machine-learning classification algorithms were 
used. For main flow cytometry plots (Fig. 8) k-means clustering was applied to FL1 height, FL1 area, and Side-
Scatter height observations from one replicate using kmeans() function in stats  package66 in R, and the clustering 
solution applied to all the data. Optimal number of clusters was determined empirically using NbClust() func-
tion from NBClust  package67 in R. To separate P2 and P1 events in permeabilized SG-stained live cells (Fig. 11), 
a Gaussian Mixture Model was fit to all the data with 2 component distributions using normalmixEM() function 
in mixtools  package68. In all FCM scatter plots, log transformations to base e (natural logarithms) are presented 
unless otherwise indicated (plots with log transformations to base 2 are used in cases where a doubling of fluo-
rescence is a specific feature of interest).
Time-kill curves were summarised in descriptive plots (Fig. 9) using non-parametric loess regression models. 
To extract summary measures of antimicrobial effect, the time-kill data was modelled using a linear mixed-effects 
model, with a fixed effect of intercept, and random slopes for antibiotic condition and replicate:
This captures the crossed experimental design where each replicate was assessed under each antimicrobial 
condition, and each replicate assessed under each condition. The antibiotic condition effect, defined as slope 
gradient for the time-kill curve, was then extracted, independent of replicate effect, from the model as a sum-
mary PD measure. Because the dependent variable is on a log scale this assumes a mono-exponential decline 
in cell populations under antimicrobial action. The dependent variables assessed were CFU count, CA + count, 
HK count, and proportion SG + . The R package lme4 was used for this  modelling69.
Antimicrobial effects extracted from these models were related to drug concentration for each antimicrobial 
using a standard sigmoid  Emax PK/PD model, of form:
where E is the PD effect (the slope gradient estimates by mixed-effects modelling above), C is the drug concen-
tration (known from experimental condition), and the remaining parameters are estimated from the data: Emax 
(maximum achievable effect of antimicrobial), EC50 (the drug concentration where half of Emax is obtained), and 
n (a scaling parameter). Models were fitted using non-linear least squares (nls() function in R.
Fluorescence profiles of bacilli (Fig. 11D) were extracted as .csv files from microscopy images using Fiji 
(ImageJ)70. This raw data was processed using a custom-built function defining local maxima in smoothed 
profiles to count fluorescent peaks.
Data availability
Data and analysis scripts are available in an Open Science Framework repository here https:// osf. io/ gwhpd/? 
view_ only= 02a61 e8134 cc4ad ca384 0df60 4e0e3 8b.
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